156 related articles for article (PubMed ID: 5564052)
1. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation].
Blanc A; Perset P
Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052
[No Abstract] [Full Text] [Related]
2. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
Komorovskaia IaM; Nechaĭ EE
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
[TBL] [Abstract][Full Text] [Related]
3. Papaverin in the treatment of geriatric patients.
Bambasová E; Bílková J; Budínská K
Act Nerv Super (Praha); 1974 Aug; 16(3):191-2. PubMed ID: 4609360
[No Abstract] [Full Text] [Related]
4. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
Cacciatori D
Clin Ter; 1979 Jun; 89(5):473-82. PubMed ID: 535324
[No Abstract] [Full Text] [Related]
5. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
Probst G; Keiser G
Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
[No Abstract] [Full Text] [Related]
6. [Clinical experiences with proxazole in the therapy of cerebrovascular diseases].
Mainieri L
Minerva Med; 1974 May; 65(40):2281-6. PubMed ID: 4422429
[No Abstract] [Full Text] [Related]
7. [On the encephalotrophic action of hydergine. Clinical study].
Garagnani Sciarretta B; Rimondini S; Martelli A
Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
[No Abstract] [Full Text] [Related]
8. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
De Gregorio G; Armeli G; Restivo S; Francolino A
Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
[No Abstract] [Full Text] [Related]
9. [The use of pyrimidine nucleosides (cytidine and uridine) in the therapy of cerebrl vascular disorders].
Ferrari G
Riv Sper Freniatr Med Leg Alien Ment; 1970 Feb; 94(1):207-16. PubMed ID: 5444685
[No Abstract] [Full Text] [Related]
10. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age].
Giovanardi F; Bisceglia G
Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003
[No Abstract] [Full Text] [Related]
11. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
Hüdepohl M; Bockelmann R
Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
[No Abstract] [Full Text] [Related]
12. [Geriatric contribution on the treatment of cerebral circulatory disorders].
Berger E; Schmidt K
Wien Klin Wochenschr; 1969 Nov; 81(46):836-8. PubMed ID: 5380789
[No Abstract] [Full Text] [Related]
13. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
Klein K
Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
[No Abstract] [Full Text] [Related]
14. Experimental cerebrovascular disorders: effects of papaverine and theophylline.
Heikkinen ER
Exp Neurol; 1977 Sep; 56(3):469-79. PubMed ID: 195830
[No Abstract] [Full Text] [Related]
15. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
Bazo AJ
J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
[No Abstract] [Full Text] [Related]
16. [Wallerox increases cerebral circulation and heart capacity].
Heynen U
Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
[No Abstract] [Full Text] [Related]
17. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
Voegt H; Haid E
Med Klin; 1970 Nov; 65(46):2031-5. PubMed ID: 5000077
[No Abstract] [Full Text] [Related]
18. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
De Gregorio G; Scaffidi L; Arcoraci A
Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
[No Abstract] [Full Text] [Related]
19. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases].
Eichhorn O
Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281
[No Abstract] [Full Text] [Related]
20. [Effect of bencyclane in obliterative arterial diseases].
Kusztos D
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
